
Opinion|Videos|July 9, 2024
Unmet Needs in the Management of cGVHD
Hannah Choe, MD, provides insights on potential areas for improvement in developing more targeted and effective treatments for chronic GVHD.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- How does the multisystemic nature of chronic GVHD (cGVHD), affecting skin, mucosa, and potentially other organs, complicate the management and treatment approach?
- What are the unmet needs and potential areas for improvement in terms of developing more targeted and effective treatments for cGVHD?
- What are the unmet needs and potential areas for improvement in terms of developing more targeted and effective treatments for cGVHD?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
2
The Targeted Pulse: New Standards in Myeloma, Melanoma, and More
3
Onvansertib Triplet Shows Dose-Dependent Frontline Benefit in RAS-Mutant Metastatic CRC
4
Pembrolizumab/Lenvatinib Show Efficacy, Safety in Clear Cell Gyn Cancers
5




















